Cargando…

DYRK1A activates NFATC1 to increase glioblastoma migration

Glioblastoma (GBM) is the most aggressive glioma, and is prone to develop resistance to chemotherapy and radiotherapy; hence, patients with glioblastoma have a high recurrence rate and a low 1‐year survival rate. In addition, the pathogenesis of glioblastoma is complex and largely unknown, and the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Heng, Sun, Qian, Chen, Shuai, Chen, Long, Jia, Wenming, Zhao, Juan, Sun, Xiulian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446559/ https://www.ncbi.nlm.nih.gov/pubmed/34309232 http://dx.doi.org/10.1002/cam4.4159

Ejemplares similares

NFATc1 phosphorylation by DYRK1A increases its protein stability
por: Liu, Heng, et al.
Publicado: (2017)

NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma
por: Xiao, Zhi-Jie, et al.
Publicado: (2017)

OSW‐1 inhibits tumor growth and metastasis by NFATc2 on triple‐negative breast cancer
por: Ding, Xiaorong, et al.
Publicado: (2020)

DYRK1A phosphorylates MEF2D and decreases its transcriptional activity
por: Wang, Pin, et al.
Publicado: (2021)

NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL‐mediated extrinsic signaling pathway
por: Xu, Sanrong, et al.
Publicado: (2018)

Dual inhibition of HSF1 and DYRK2 impedes cancer progression
por: Tandon, Vasudha, et al.
Publicado: (2023)

Dual-specificity tyrosine phosphorylation-regulated kinase 1A ameliorates insulin resistance in neurons by up-regulating IRS-1 expression
por: Tian, Shijiao, et al.
Publicado: (2019)

Dcf1 induces glioblastoma cells apoptosis by blocking autophagy
por: Luo, Guanghong, et al.
Publicado: (2021)

Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c‐Fos/NFATc1 signaling pathway
por: Jiang, Wenli, et al.
Publicado: (2020)

MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial‐mesenchymal transition of glioblastoma cells in vitro and in vivo
por: Liu, Tie, et al.
Publicado: (2019)

The role of NPY2R/NFATc1/DYRK1A regulatory axis in sebaceous glands for sebum synthesis
por: Yang, Tao, et al.
Publicado: (2023)

Tumor Suppressor DYRK1A Effects on Proliferation and Chemoresistance of AML Cells by Downregulating c-Myc
por: Liu, Qiang, et al.
Publicado: (2014)

Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy
por: Cui, Xin, et al.
Publicado: (2020)

Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial‐mesenchymal transition, invasion, and migration
por: Zhao, Yue, et al.
Publicado: (2018)

E3 Ligase SCF(βTrCP)-induced DYRK1A Protein Degradation Is Essential for Cell Cycle Progression in HEK293 Cells
por: Liu, Qiang, et al.
Publicado: (2016)

Upregulation of long noncoding RNA TUG1 promotes cervical cancer cell proliferation and migration
por: Hu, Yingying, et al.
Publicado: (2017)

Long noncoding RNA RP11‐547D24.1 regulates proliferation and migration in papillary thyroid carcinoma: Identification and validation of a novel long noncoding RNA through integrated analysis of TCGA database
por: Guo, Kai, et al.
Publicado: (2019)

Chi3l1 Is a Modulator of Glioma Stem Cell States and a Therapeutic Target in Glioblastoma
por: Guetta-Terrier, Charlotte, et al.
Publicado: (2023)

MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells
por: Dong, Zhen, et al.
Publicado: (2019)

NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1
por: Marques, Carolina, et al.
Publicado: (2021)

FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells
por: Li, Jin‐Li, et al.
Publicado: (2019)

Nitidine chloride suppresses epithelial‐mesenchymal transition and stem cell‐like properties in glioblastoma by regulating JAK2/STAT3 signaling
por: Jia, Mingbo, et al.
Publicado: (2021)

Upregulation of LncRNA‐HIT promotes migration and invasion of non‐small cell lung cancer cells by association with ZEB1
por: Jia, Xiaojing, et al.
Publicado: (2016)

Dabigatran antagonizes growth, cell‐cycle progression, migration, and endothelial tube formation induced by thrombin in breast and glioblastoma cell lines
por: Vianello, Fabrizio, et al.
Publicado: (2016)

DYRK1A-mediated PLK2 phosphorylation regulates the proliferation and invasion of glioblastoma cells
por: Tan, Shichuan, et al.
Publicado: (2023)

Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cells
por: Chen, Hua, et al.
Publicado: (2017)

Overexpression of HACE1 in gastric cancer inhibits tumor aggressiveness by impeding cell proliferation and migration
por: Chen, Ying‐ling, et al.
Publicado: (2018)

Abi1 gene silencing by short hairpin RNA impairs Bcr-Abl-induced cell adhesion and migration in vitro and leukemogenesis in vivo
por: Yu, Weidong, et al.
Publicado: (2008)

Confined migration promotes cancer metastasis through resistance to anoikis and increased invasiveness
por: Fanfone, Deborah, et al.
Publicado: (2022)

LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR‐20a‐5p/HMGA2 axis in breast cancer
por: Zhao, Wenyan, et al.
Publicado: (2018)

Aquaporin 1 elicits cell motility and coordinates vascular bed formation by downregulating thrombospondin type‐1 domain‐containing 7A in glioblastoma
por: Oishi, Masahiro, et al.
Publicado: (2020)

Matrine induces senescence of human glioblastoma cells through suppression of the IGF1/PI3K/AKT/p27 signaling pathway
por: Zhou, Wenjing, et al.
Publicado: (2018)

Global hypo-methylation in a proportion of glioblastoma enriched for an astrocytic signature is associated with increased invasion and altered immune landscape
por: Boot, James, et al.
Publicado: (2022)

Expression of miR‐634 in gastric carcinoma and its effects on proliferation, migration, and invasion of gastric cancer cells
por: Guo, Jiao, et al.
Publicado: (2018)

Global phosphoproteomics reveals DYRK1A regulates CDK1 activity in glioblastoma cells
por: Recasens, Ariadna, et al.
Publicado: (2021)

Increased expression of miR‐641 contributes to erlotinib resistance in non‐small‐cell lung cancer cells by targeting NF1
por: Chen, Juan, et al.
Publicado: (2018)

Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA‐101 in glioblastoma
por: Cai, Tao, et al.
Publicado: (2018)

Abnormal expression and methylation of PRR34‐AS1 are associated with adverse outcomes in acute myeloid leukemia
por: Nan, Fang‐yu, et al.
Publicado: (2021)

Crizotinib targets in glioblastoma stem cells
por: Junca, Audelaure, et al.
Publicado: (2017)

A comprehensive genome‐wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma
por: Cui, Hongxia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_urmcdke20jadc92dl0ectgjt8n